1. Home
  2. EYPT vs GLDD Comparison

EYPT vs GLDD Comparison

Compare EYPT & GLDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • GLDD
  • Stock Information
  • Founded
  • EYPT 1987
  • GLDD 1890
  • Country
  • EYPT United States
  • GLDD United States
  • Employees
  • EYPT N/A
  • GLDD N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • GLDD Military/Government/Technical
  • Sector
  • EYPT Industrials
  • GLDD Industrials
  • Exchange
  • EYPT Nasdaq
  • GLDD Nasdaq
  • Market Cap
  • EYPT 741.0M
  • GLDD 770.3M
  • IPO Year
  • EYPT 2005
  • GLDD 2006
  • Fundamental
  • Price
  • EYPT $11.09
  • GLDD $11.35
  • Analyst Decision
  • EYPT Strong Buy
  • GLDD Buy
  • Analyst Count
  • EYPT 7
  • GLDD 1
  • Target Price
  • EYPT $24.29
  • GLDD $14.00
  • AVG Volume (30 Days)
  • EYPT 643.4K
  • GLDD 446.4K
  • Earning Date
  • EYPT 08-06-2025
  • GLDD 08-05-2025
  • Dividend Yield
  • EYPT N/A
  • GLDD N/A
  • EPS Growth
  • EYPT N/A
  • GLDD 63.54
  • EPS
  • EYPT N/A
  • GLDD 1.06
  • Revenue
  • EYPT $51,898,000.00
  • GLDD $830,567,000.00
  • Revenue This Year
  • EYPT N/A
  • GLDD $9.62
  • Revenue Next Year
  • EYPT N/A
  • GLDD $5.83
  • P/E Ratio
  • EYPT N/A
  • GLDD $10.71
  • Revenue Growth
  • EYPT 2.99
  • GLDD 24.40
  • 52 Week Low
  • EYPT $3.91
  • GLDD $7.51
  • 52 Week High
  • EYPT $13.99
  • GLDD $12.89
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 61.85
  • GLDD 50.33
  • Support Level
  • EYPT $10.22
  • GLDD $11.35
  • Resistance Level
  • EYPT $11.28
  • GLDD $11.70
  • Average True Range (ATR)
  • EYPT 0.71
  • GLDD 0.36
  • MACD
  • EYPT 0.04
  • GLDD 0.04
  • Stochastic Oscillator
  • EYPT 89.89
  • GLDD 64.05

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About GLDD Great Lakes Dredge & Dock Corporation

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.

Share on Social Networks: